TIMP1 and hepatocellular carcinoma: Intriguingly, our findings of TIMP-1 expression in HCC samples are consistent with results from Lempinen's group showing that HCC patients with low concentrations of serum TIMP-1 have significantly better overall survival than those with high concentrations of serum TIMP-1 [22].